CA2957432C - Moving-horizon state-initializer for control applications - Google Patents
Moving-horizon state-initializer for control applications Download PDFInfo
- Publication number
- CA2957432C CA2957432C CA2957432A CA2957432A CA2957432C CA 2957432 C CA2957432 C CA 2957432C CA 2957432 A CA2957432 A CA 2957432A CA 2957432 A CA2957432 A CA 2957432A CA 2957432 C CA2957432 C CA 2957432C
- Authority
- CA
- Canada
- Prior art keywords
- state
- model
- time
- sensor
- cgm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000005259 measurement Methods 0.000 claims abstract description 53
- 238000005070 sampling Methods 0.000 claims abstract description 26
- 239000008103 glucose Substances 0.000 claims description 66
- 238000000034 method Methods 0.000 claims description 62
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 60
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 55
- 102000004877 Insulin Human genes 0.000 claims description 30
- 108090001061 Insulin Proteins 0.000 claims description 30
- 229940125396 insulin Drugs 0.000 claims description 30
- 238000005457 optimization Methods 0.000 claims description 27
- 238000012544 monitoring process Methods 0.000 claims description 19
- 238000004422 calculation algorithm Methods 0.000 claims description 18
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 17
- 239000008280 blood Substances 0.000 claims description 15
- 210000004369 blood Anatomy 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 13
- 238000012377 drug delivery Methods 0.000 claims description 9
- 230000001934 delay Effects 0.000 claims description 7
- 230000001788 irregular Effects 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 238000010276 construction Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 206010028980 Neoplasm Diseases 0.000 claims description 3
- 230000001684 chronic effect Effects 0.000 claims description 3
- 206010002091 Anaesthesia Diseases 0.000 claims description 2
- 230000037005 anaesthesia Effects 0.000 claims description 2
- 230000036772 blood pressure Effects 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 238000001631 haemodialysis Methods 0.000 claims description 2
- 230000000322 hemodialysis Effects 0.000 claims description 2
- 208000032839 leukemia Diseases 0.000 claims description 2
- 238000004886 process control Methods 0.000 claims description 2
- 230000006870 function Effects 0.000 description 52
- 210000000496 pancreas Anatomy 0.000 description 19
- 206010012601 diabetes mellitus Diseases 0.000 description 12
- 230000008859 change Effects 0.000 description 11
- 230000004044 response Effects 0.000 description 11
- 238000013459 approach Methods 0.000 description 9
- 230000001360 synchronised effect Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 6
- 238000013461 design Methods 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 238000011217 control strategy Methods 0.000 description 3
- 238000000126 in silico method Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 230000004043 responsiveness Effects 0.000 description 3
- 230000036962 time dependent Effects 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- 230000003190 augmentative effect Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000001610 euglycemic effect Effects 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 108010067035 Pancrelipase Proteins 0.000 description 1
- 229940123452 Rapid-acting insulin Drugs 0.000 description 1
- 108010026951 Short-Acting Insulin Proteins 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002089 crippling effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000008571 general function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/18—General characteristics of the apparatus with alarm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Pathology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- External Artificial Organs (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Feedback Control In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462034132P | 2014-08-06 | 2014-08-06 | |
| US62/034,132 | 2014-08-06 | ||
| PCT/US2015/043763 WO2016022650A1 (en) | 2014-08-06 | 2015-08-05 | Moving-horizon state-initializer for control applications |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2957432A1 CA2957432A1 (en) | 2016-02-11 |
| CA2957432C true CA2957432C (en) | 2017-07-25 |
Family
ID=55264479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2957432A Active CA2957432C (en) | 2014-08-06 | 2015-08-05 | Moving-horizon state-initializer for control applications |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9984773B2 (enExample) |
| EP (1) | EP3177344B1 (enExample) |
| JP (1) | JP6810991B2 (enExample) |
| CN (1) | CN106714874B (enExample) |
| AU (1) | AU2015301146B2 (enExample) |
| CA (1) | CA2957432C (enExample) |
| WO (1) | WO2016022650A1 (enExample) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8417311B2 (en) | 2008-09-12 | 2013-04-09 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
| US9561324B2 (en) | 2013-07-19 | 2017-02-07 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
| GB2523989B (en) | 2014-01-30 | 2020-07-29 | Insulet Netherlands B V | Therapeutic product delivery system and method of pairing |
| DE102015000845A1 (de) * | 2015-01-27 | 2016-07-28 | W.O.M. World Of Medicine Gmbh | Verfahren und Vorrichtung zur Regelung der Temperatur des Gasstroms bei medizintechnischen Vorrichtungen |
| AU2016219961B2 (en) | 2015-02-18 | 2020-07-02 | Insulet Corporation | Fluid delivery and infusion devices, and methods of use thereof |
| HK1257246A1 (zh) | 2016-01-13 | 2019-10-18 | Bigfoot Biomedical, Inc. | 糖尿病管理系统的用户界面 |
| HK1256995A1 (zh) | 2016-01-14 | 2019-10-11 | Bigfoot Biomedical, Inc. | 药物输送设备、系统和方法中的阻塞解决方案 |
| US10307538B2 (en) | 2016-01-14 | 2019-06-04 | Bigfoot Biomedical, Inc. | Adjusting insulin delivery rates |
| US12383166B2 (en) | 2016-05-23 | 2025-08-12 | Insulet Corporation | Insulin delivery system and methods with risk-based set points |
| WO2018058041A1 (en) | 2016-09-23 | 2018-03-29 | Insulet Corporation | Fluid delivery device with sensor |
| US11096624B2 (en) | 2016-12-12 | 2021-08-24 | Bigfoot Biomedical, Inc. | Alarms and alerts for medication delivery devices and systems |
| US11027063B2 (en) | 2017-01-13 | 2021-06-08 | Bigfoot Biomedical, Inc. | Insulin delivery methods, systems and devices |
| US10881793B2 (en) | 2017-01-13 | 2021-01-05 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US10758675B2 (en) | 2017-01-13 | 2020-09-01 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US10500334B2 (en) | 2017-01-13 | 2019-12-10 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| EP3568860B1 (en) | 2017-01-13 | 2025-12-10 | Insulet Corporation | Insulin delivery methods, systems and devices |
| CN116531603A (zh) | 2017-05-05 | 2023-08-04 | 伊莱利利公司 | 生理葡萄糖的闭环控制 |
| EP3438858A1 (en) | 2017-08-02 | 2019-02-06 | Diabeloop | Closed-loop blood glucose control systems and methods |
| JP7133625B2 (ja) | 2017-12-21 | 2022-09-08 | イーライ リリー アンド カンパニー | 生理的グルコースの閉ループ制御 |
| USD928199S1 (en) | 2018-04-02 | 2021-08-17 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
| US11565043B2 (en) | 2018-05-04 | 2023-01-31 | Insulet Corporation | Safety constraints for a control algorithm based drug delivery system |
| CA3103479A1 (en) | 2018-06-22 | 2019-12-26 | Eli Lilly And Company | Insulin and pramlintide delivery systems, methods, and devices |
| CN112789070A (zh) | 2018-09-28 | 2021-05-11 | 英赛罗公司 | 人造胰腺系统的活动模式 |
| US11565039B2 (en) | 2018-10-11 | 2023-01-31 | Insulet Corporation | Event detection for drug delivery system |
| USD920343S1 (en) | 2019-01-09 | 2021-05-25 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
| US11801344B2 (en) | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
| US11935637B2 (en) | 2019-09-27 | 2024-03-19 | Insulet Corporation | Onboarding and total daily insulin adaptivity |
| EP4069082B1 (en) | 2019-12-06 | 2024-06-05 | Insulet Corporation | Techniques and devices providing adaptivity and personalization in diabetes treatment |
| US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
| AU2021206190A1 (en) | 2020-01-06 | 2022-08-18 | Insulet Corporation | Prediction of meal and/or exercise events based on persistent residuals |
| EP4100958A1 (en) | 2020-02-03 | 2022-12-14 | Insulet Corporation | Use of fuzzy logic in predicting user behavior affecting blood glucose concentration |
| US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
| US11986630B2 (en) | 2020-02-12 | 2024-05-21 | Insulet Corporation | Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk |
| US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
| US11324889B2 (en) | 2020-02-14 | 2022-05-10 | Insulet Corporation | Compensation for missing readings from a glucose monitor in an automated insulin delivery system |
| US12495994B2 (en) | 2020-02-20 | 2025-12-16 | Insulet Corporation | Meal bolus subcategories in model based insulin therapy |
| US11607493B2 (en) | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
| US11132352B1 (en) | 2020-05-13 | 2021-09-28 | International Business Machines Corporation | Utilizing local IoT devices to reconcile data mismatches |
| CA3176599A1 (en) | 2020-05-27 | 2021-12-02 | Dexcom, Inc. | Glucose prediction using machine learning and time series glucose measurements |
| US12121700B2 (en) | 2020-07-22 | 2024-10-22 | Insulet Corporation | Open-loop insulin delivery basal parameters based on insulin delivery records |
| US11684716B2 (en) | 2020-07-31 | 2023-06-27 | Insulet Corporation | Techniques to reduce risk of occlusions in drug delivery systems |
| US12128215B2 (en) | 2020-09-30 | 2024-10-29 | Insulet Corporation | Drug delivery device with integrated optical-based glucose monitor |
| WO2022072618A1 (en) | 2020-09-30 | 2022-04-07 | Insulet Corporation | Secure wireless communications between a glucose monitor and other devices |
| CA3191704A1 (en) * | 2021-01-25 | 2022-07-28 | Dexcom, Inc. | Bayesian framework for personalized model identification and prediction of future blood glucose in type 1 diabetes using easily accessible patient data |
| US11160925B1 (en) | 2021-01-29 | 2021-11-02 | Insulet Corporation | Automatic drug delivery system for delivery of a GLP-1 therapeutic |
| US12431229B2 (en) | 2021-03-10 | 2025-09-30 | Insulet Corporation | Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions |
| US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
| CN113223721B (zh) * | 2021-03-23 | 2022-07-12 | 杭州电子科技大学 | 一种新型冠状病毒肺炎的预测控制模型 |
| US12496398B2 (en) | 2021-05-28 | 2025-12-16 | Insulet Corporation | Threshold based automatic glucose control response |
| US12406760B2 (en) | 2021-06-07 | 2025-09-02 | Insulet Corporation | Exercise safety prediction based on physiological conditions |
| US12514980B2 (en) | 2021-06-30 | 2026-01-06 | Insulet Corporation | Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase |
| US12521486B2 (en) | 2021-07-16 | 2026-01-13 | Insulet Corporation | Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems |
| US11738144B2 (en) | 2021-09-27 | 2023-08-29 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
| US11439754B1 (en) | 2021-12-01 | 2022-09-13 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
| WO2024147928A1 (en) | 2023-01-06 | 2024-07-11 | Insulet Corporation | Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation |
| CN117170238B (zh) * | 2023-09-15 | 2024-04-16 | 四川大学 | 基于协作分布式mpc的异构无人机集群搜索算法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8774886B2 (en) * | 2006-10-04 | 2014-07-08 | Dexcom, Inc. | Analyte sensor |
| US8364231B2 (en) * | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
| US20080269714A1 (en) * | 2007-04-25 | 2008-10-30 | Medtronic Minimed, Inc. | Closed loop/semi-closed loop therapy modification system |
| US7717903B2 (en) * | 2007-09-06 | 2010-05-18 | M2 Group Holdings, Inc. | Operating an infusion pump system |
| US7695434B2 (en) * | 2007-10-19 | 2010-04-13 | Lifescan Scotland, Ltd. | Medical device for predicting a user's future glycemic state |
| US20100262117A1 (en) * | 2007-11-02 | 2010-10-14 | University Of Virginia Patent Foundation | Predictive control based system and method for control of insulin delivery in diabetes using glucose sensing |
| DE112009000224T5 (de) * | 2008-01-31 | 2011-01-05 | Fisher-Rosemount Systems, Inc., Austin | Robuster andaptiver modellprädiktiver Regler mit Abstimmung zum Ausgleich einer Modellfehlanpassung |
| US8734422B2 (en) * | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
| US20100057040A1 (en) * | 2008-08-31 | 2010-03-04 | Abbott Diabetes Care, Inc. | Robust Closed Loop Control And Methods |
| US8062249B2 (en) * | 2009-03-31 | 2011-11-22 | Abbott Diabetes Care Inc. | Overnight closed-loop insulin delivery with model predictive control and glucose measurement error model |
| WO2010135654A2 (en) * | 2009-05-22 | 2010-11-25 | Abbott Diabetes Care Inc. | Safety features for integrated insulin delivery system |
| US8597274B2 (en) * | 2009-05-22 | 2013-12-03 | Abbott Diabetes Care Inc. | Usability features for integrated insulin delivery system |
| EP2432393A2 (en) * | 2009-05-22 | 2012-03-28 | Abbott Diabetes Care, Inc. | Method and system for reducing false hypoglycemia alarm occurrence |
| WO2011014851A1 (en) * | 2009-07-31 | 2011-02-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte monitoring system calibration accuracy |
| US9858386B2 (en) * | 2009-11-02 | 2018-01-02 | Universita Degli Studi Di Padova | Method to recalibrate continuous glucose monitoring data on-line |
| US20110313680A1 (en) * | 2010-06-22 | 2011-12-22 | Doyle Iii Francis J | Health Monitoring System |
| EP2628115B1 (en) * | 2010-10-12 | 2015-06-03 | The Regents of The University of California | Insulin delivery device |
| CA3101645A1 (en) * | 2011-09-28 | 2013-04-04 | Abbott Diabetes Care, Inc. | Methods, devices and systems for analyte monitoring management |
| WO2013104006A2 (en) * | 2012-01-08 | 2013-07-11 | Sensor Platforms, Inc. | System and method for calibrating sensors for different operating environments |
| US9907909B2 (en) * | 2012-12-20 | 2018-03-06 | Animas Corporation | Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas |
| EP2943150B1 (en) * | 2013-01-14 | 2018-12-05 | The Regents of The University of California | Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type i diabetes applications |
| US9486171B2 (en) * | 2013-03-15 | 2016-11-08 | Tandem Diabetes Care, Inc. | Predictive calibration |
| CN103605878B (zh) * | 2013-08-19 | 2016-03-30 | 浙江大学 | 一种基于数据建模和模型移植的通用血糖预测方法 |
| CN103793594A (zh) * | 2013-12-30 | 2014-05-14 | 上海交通大学医学院附属瑞金医院 | 一种构建肠道-胰岛调控轴相关功能评估模型的方法与应用 |
| US10314547B2 (en) * | 2014-04-09 | 2019-06-11 | Halo Wearables LLC | Calibration of a wearable medical device |
| US9949673B2 (en) * | 2014-08-26 | 2018-04-24 | MAXIM lNTEGRATED PRODUCTS, INC. | System, method and apparatus with multiple reservoirs for in situ calibration of implantable sensors |
-
2015
- 2015-08-05 CN CN201580051005.XA patent/CN106714874B/zh active Active
- 2015-08-05 WO PCT/US2015/043763 patent/WO2016022650A1/en not_active Ceased
- 2015-08-05 EP EP15829714.3A patent/EP3177344B1/en active Active
- 2015-08-05 CA CA2957432A patent/CA2957432C/en active Active
- 2015-08-05 JP JP2017506924A patent/JP6810991B2/ja active Active
- 2015-08-05 AU AU2015301146A patent/AU2015301146B2/en active Active
-
2017
- 2017-02-04 US US15/424,824 patent/US9984773B2/en active Active
-
2018
- 2018-05-27 US US15/990,634 patent/US11189381B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9984773B2 (en) | 2018-05-29 |
| CA2957432A1 (en) | 2016-02-11 |
| AU2015301146A1 (en) | 2017-03-16 |
| US11189381B2 (en) | 2021-11-30 |
| JP2017523852A (ja) | 2017-08-24 |
| WO2016022650A1 (en) | 2016-02-11 |
| EP3177344B1 (en) | 2023-06-28 |
| JP6810991B2 (ja) | 2021-01-13 |
| CN106714874B (zh) | 2019-10-08 |
| EP3177344A1 (en) | 2017-06-14 |
| US20170147781A1 (en) | 2017-05-25 |
| EP3177344A4 (en) | 2017-08-09 |
| US20180277253A1 (en) | 2018-09-27 |
| CN106714874A (zh) | 2017-05-24 |
| AU2015301146B2 (en) | 2020-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2957432C (en) | Moving-horizon state-initializer for control applications | |
| EP1881786B1 (en) | Fully automated control system for type 1 diabetes | |
| EP2166946B1 (en) | Lqg artificial pancreas control system and related method | |
| JP6810989B2 (ja) | １型糖尿病用の人工膵臓のためのモデル予測制御問題における日周目標範囲調節 | |
| Turksoy et al. | Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement | |
| EP3052161B1 (en) | System for controlling a tuning factor due to sensor replacement for closed-loop controller in an artificial pancreas | |
| WO2009059187A1 (en) | Predictive control based system and method for control of insulin delivery in diabetes using glucose sensing | |
| González et al. | Stable impulsive zone model predictive control for type 1 diabetic patients based on a long‐term model | |
| KR20150097731A (ko) | 인공 췌장의 혼성 목표 제어 및 범위 제어 모델 예측 제어를 위한 방법 및 시스템 | |
| Pagkalos et al. | Bio-Inspired Glucose Control in Diabetes Based on an Analogue Implementation of a $\beta $-Cell Model | |
| MohammadRidha et al. | A variable reference trajectory for model-free glycemia regulation | |
| Doyle et al. | I. Glucose control strategies for treating type 1 diabetes mellitus | |
| Batora et al. | Bihormonal control of blood glucose in people with type 1 diabetes | |
| Gondhalekar et al. | State Estimation with Sensor Recalibrations and Asynchronous Measurements for MPC of an Artificial Pancreas to Treat T1DM | |
| Rakan et al. | Artificial pancreas: Avoiding hyperglycemia and hypoglycemia for type one diabetes | |
| Ata et al. | Model based control of artificial pancreas under meal disturbances | |
| Chandrasekhar et al. | An android phone based artificial pancreas system for type-1 diabetic patients | |
| Boiroux et al. | Nonlinear model predictive control for an artificial β-cell | |
| Abuin et al. | Control by pulses under MPC schemes, with applications to artificial pancreas | |
| Karra et al. | Predictive control of blood glucose concentration in type-I diabetic patients using linear input-output models | |
| HK1226677A1 (en) | System for controlling a tuning factor due to sensor replacement for closed-loop controller in an artificial pancreas | |
| HK1226677B (en) | System for controlling a tuning factor due to sensor replacement for closed-loop controller in an artificial pancreas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20170206 |